SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-23-014573
Filing Date
2023-05-01
Accepted
2023-05-01 16:14:46
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 moonlakes-3atm.htm S-3 350724
2 EX-FILING FEES exhibit107-sx3.htm EX-FILING FEES 44581
3 EX-4.1 exhibit41-sx3.htm EX-4.1 421394
4 EX-4.2 exhibit42-sx3.htm EX-4.2 472912
5 EX-5.1 exhibit51-sx3.htm EX-5.1 54339
6 EX-23.1 exhibit231-sx3.htm EX-23.1 2765
7 logo1aa.jpg GRAPHIC 26726
8 prospectuscover1a.jpg GRAPHIC 54812
  Complete submission text file 0001628280-23-014573.txt   1460178
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271546 | Film No.: 23873832
SIC: 2834 Pharmaceutical Preparations